FDA Warning Letter to Warrior Labz SARMS

FDA cited Warrior Labz for marketing BPC-157 and TB-500 products as unapproved new drugs.

Not legal or medical advice.

This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.

U.S. Food and Drug AdministrationWarning letterPublished
Docket / Citation
655280
Published
2023-06-12